Acute cardiac care & resuscitation

Percutaneous Coronary Intervention in Multivessel Disease and Infarct-Related Cardiogenic Shock: A DanGer Shock Substudy

JACC Cardiovasc IntervPublished Secondary analysis of the DanGer Shock randomised trial

Primary result · All-cause mortalityResult — go to the resultAdjusted odds ratio 0.40 95% CI 0.19–0.83

Authors' conclusion

Immediate multivessel PCI was associated with 60% lower odds of all-cause mortality compared with culprit-only PCI.

Study context

Population
STEMI-related cardiogenic shock with multivessel disease (≥1 nonculprit stenosis ≥70%), excluding comatose patients resuscitated from cardiac arrest and isolated left main culpritof 355 in DanGer Shock
Participants
221 participants
Comparison
Immediate multivessel percutaneous coronary intervention (PCI) vs culprit-only PCI
  • Immediate multivessel PCIn = 103
  • Culprit-only PCIn = 118reference
Primary endpoint
All-cause mortality
Follow-up
180 days
Methodological detailsexploratory substudy, multicentre, as-treated analysis
  • Exploratory substudy
  • Multicentre
  • As-treated analysis

Primary result

As reported in the abstract

median follow-up 45 days (Q1-Q3: 2-180 days)

Adjusted odds ratio

0.40

95% CI 0.19–0.83

Events by treatment group

Immediate multivessel PCIvs Culprit-only PCI
adjusted OR 0.40 (95% CI 0.19–0.83)

Secondary outcomes

Renal replacement therapy and acute kidney injury

Immediate multivessel PCI not associated with the secondary outcomes

Original publication

Percutaneous Coronary Intervention in Multivessel Disease and Infarct-Related Cardiogenic Shock: A DanGer Shock Substudy. JACC Cardiovasc Interv. Published 22 September 2025. doi:10.1016/j.jcin.2025.07.035

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.